BRPI0415923A - uso de antagonistas de neuroquinina no tratamento de incontigência urinária - Google Patents

uso de antagonistas de neuroquinina no tratamento de incontigência urinária

Info

Publication number
BRPI0415923A
BRPI0415923A BRPI0415923-3A BRPI0415923A BRPI0415923A BR PI0415923 A BRPI0415923 A BR PI0415923A BR PI0415923 A BRPI0415923 A BR PI0415923A BR PI0415923 A BRPI0415923 A BR PI0415923A
Authority
BR
Brazil
Prior art keywords
treatment
urinary incontinence
neurokinin antagonists
antagonists
urinary
Prior art date
Application number
BRPI0415923-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Paul William Glue
Kevin Hall Mcallister
Eckhard Weber
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34520229&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0415923(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0415923A publication Critical patent/BRPI0415923A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
BRPI0415923-3A 2003-10-27 2004-10-26 uso de antagonistas de neuroquinina no tratamento de incontigência urinária BRPI0415923A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51479103P 2003-10-27 2003-10-27
PCT/EP2004/012081 WO2005039563A2 (en) 2003-10-27 2004-10-26 Use of neurokinin antagonists in the treatment of urinary incontinence

Publications (1)

Publication Number Publication Date
BRPI0415923A true BRPI0415923A (pt) 2006-12-26

Family

ID=34520229

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415923-3A BRPI0415923A (pt) 2003-10-27 2004-10-26 uso de antagonistas de neuroquinina no tratamento de incontigência urinária

Country Status (9)

Country Link
US (1) US7776851B2 (https=)
EP (2) EP1686985A2 (https=)
JP (1) JP2007509184A (https=)
CN (1) CN1874766A (https=)
AU (1) AU2004283038B9 (https=)
BR (1) BRPI0415923A (https=)
CA (1) CA2543552A1 (https=)
MX (1) MXPA06004688A (https=)
WO (1) WO2005039563A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1938804A1 (en) * 2006-12-22 2008-07-02 Novartis AG Pharmaceutical formulation comprising neurokinin antagonist

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472978A (en) * 1991-07-05 1995-12-05 Merck Sharp & Dohme Ltd. Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
FR2700472B1 (fr) * 1993-01-19 1995-02-17 Rhone Poulenc Rorer Sa Association synergisante ayant un effet antagoniste des récepteurs NK1 et NK2.
MY132550A (en) * 1996-08-22 2007-10-31 Novartis Ag Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists
GB0015246D0 (en) * 2000-06-22 2000-08-16 Astrazeneca Ab Method for the treatment of urinary incontinence
US6664253B2 (en) * 2000-10-17 2003-12-16 Boehringer Ingelheim Pharma Kg Neurokinin antagonists
CA2432543A1 (en) * 2000-12-22 2002-07-04 Takeda Chemical Industries, Ltd. Combination drugs
WO2002072145A1 (en) * 2001-03-14 2002-09-19 Ono Pharmaceutical Co., Ltd. Remedies for depression containing ep1 antagonist as the active ingredient
ATE427310T1 (de) * 2002-01-18 2009-04-15 Kyorin Seiyaku Kk Kondensierte bicyclische pyrimidinderivate
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds
ATE370140T1 (de) * 2002-03-26 2007-09-15 Kyorin Seiyaku Kk Kondensierte bicyclische pyrimidinderivate
KR20040099367A (ko) * 2002-03-26 2004-11-26 교린 세이야꾸 가부시키 가이샤 타키키닌 수용체 길항제로서의 축합 바이사이클릭 피리딘 유도체

Also Published As

Publication number Publication date
US7776851B2 (en) 2010-08-17
CA2543552A1 (en) 2005-05-06
AU2004283038A1 (en) 2005-05-06
MXPA06004688A (es) 2006-07-05
EP2158910A1 (en) 2010-03-03
AU2004283038B9 (en) 2008-04-24
EP1686985A2 (en) 2006-08-09
CN1874766A (zh) 2006-12-06
WO2005039563A2 (en) 2005-05-06
AU2004283038B2 (en) 2008-01-31
JP2007509184A (ja) 2007-04-12
US20070149504A1 (en) 2007-06-28
WO2005039563A3 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
BR0108678A (pt) Novos compostos
BR0316375A (pt) Diazinopirimidinas
SE0302811D0 (sv) Novel compounds
BR0111667A (pt) Novos compostos
SE0104140D0 (sv) Novel Compounds
BR0309873A (pt) Pirazolo-pirimidin-4-onas substituìdas
BR0314393A (pt) Piperazinas heterocìclicas substituìdas para o tratamento de esquizofrenia
TR200302214T4 (tr) Psoriasis tedavisi için kullanilan pteridine bileşkenleri
DOP2002000433A (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituidas y su uso
PT1506185E (pt) Compostos novos e sua utilizacao
BRPI0413094A (pt) derivados de quinolina e seu uso em terapia
BRPI0511532A (pt) composto, uso do mesmo, composição farmacêutica, e, métodos para a terapia de distúrbios gastrointestinais funcionais e de sìndrome do intestino irritável em um animal de sangue quente, e para a preparação de um composto
SE0401762D0 (sv) Novel compounds
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
BRPI0414948A (pt) derivados de pirazolo-e-imidazo pirimidina
CY1108377T1 (el) Χρηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια της ακρατειας ουρων
BRPI0406596A (pt) Métodos para tratar a dor articular e melhorar o sono utilizando um agonista/antagonista de estrogênio
BRPI0407913A (pt) antagonistas receptores de ccr-3
BRPI0416873A (pt) derivados de benzoxazina e usos dos mesmos
BRPI0415678A (pt) compostos de pirimidina para o tratamento de inflamação
TW200635917A (en) Novel compounds
SE0303280D0 (sv) Novel compounds
BRPI0416745A (pt) novos compostos
MXPA04001419A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson.
SE0403086D0 (sv) Compounds

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014.